Low-Activity V89L Variant in SRD5A2 Is Associated with...

European Urology 2007 Vol. 52; Iss. 4

Low-Activity V89L Variant in SRD5A2 Is Associated with Aggressive Prostate Cancer Risk: An Explanation for the Adverse Effects Observed in Chemoprevention Trials Using 5-Alpha-Reductase Inhibitors

Olivier Cussenot, Abdel-Rahmène Azzouzi, Nathalie Nicolaiew, Philippe Mangin, Luc Cormier, Georges Fournier, Antoine Valeri, Géraldine Cancel-Tassin
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
52
Year:
2007
Language:
english
Pages:
8
DOI:
10.1016/j.eururo.2007.04.008
File:
PDF, 153 KB
english, 2007
Conversion to is in progress
Conversion to is failed